| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 06/24/2004 | WO2004052310A2 Process and intermediates for synthesis entecavir |
| 06/24/2004 | WO2004052288A2 2-nh-heteroarylimidazoles with antibacterial activity |
| 06/24/2004 | WO2003093461A8 Genomic library of cyanophage s-2l and functional analysis |
| 06/24/2004 | WO2003047589A8 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 06/24/2004 | US20040122235 such as N-(2-Phenoxyphenyl)-N'-(thiazol-2-yl)urea; for treating diseases in which increasing glucokinase activity is beneficial (diabetes) |
| 06/24/2004 | US20040122228 Antidiabetic agents; dipeptidyl-peptidase inhibitors; antiarthritic agents; obesity; osteoporosis |
| 06/24/2004 | US20040122046 NPY-5 antagonists |
| 06/24/2004 | CA2735485A1 Process for preparing the antiviral agent [1s-(1.alpha., 3.alpha., 4.beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecycloppentyl]-6h-purin-6-one |
| 06/24/2004 | CA2548608A1 Anhydrous crystalline form of valacyclovir hydrochloride |
| 06/24/2004 | CA2508811A1 Process for preparing the antiviral agent [1s-(1alpha, 3 alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6h-purin-6-one |
| 06/24/2004 | CA2508147A1 2-nh-heteroarylimidazoles with antibacterial activity |
| 06/23/2004 | EP1430050A1 Piperidine derivatives and their use as modulators of chemokine (especially ccr3) activity |
| 06/23/2004 | EP1429775A1 Methods of treating pulmonary disease |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/23/2004 | EP1210347B1 Carbocyclic nucleosides and process for obtaining such |
| 06/17/2004 | WO2004050656A1 1,3-dihydroimidazole fused-ring compound |
| 06/17/2004 | WO2004050035A2 Benzimidazoles and analogs thereof as antivirals |
| 06/17/2004 | US20040116454 Pyrazole compounds useful as protein kinase inhibitors |
| 06/17/2004 | US20040116429 5-Phenylpyrimidines, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi |
| 06/17/2004 | US20040116328 Condensed imidazole derivatives |
| 06/17/2004 | CA2507763A1 Fused 1,3-dihydro-imidazole ring compounds |
| 06/16/2004 | EP1427849A2 Method of screening for drug hypersensitivity reaction |
| 06/16/2004 | EP1427710A2 Method for the production of cna |
| 06/16/2004 | EP1427413A2 2-aroylimidazole compounds for treating cancer |
| 06/16/2004 | EP1427407A2 Fatty amine drug conjugates |
| 06/16/2004 | EP1056745B1 6,9-disubstituted 2- trans-(4- aminocyclohexyl) amino]purines |
| 06/16/2004 | EP1043324B1 Purine derivatives and medicine containing the same as the active ingredient |
| 06/16/2004 | EP0977725B1 New fatty acid derivatives |
| 06/16/2004 | CN1153769C Purine derivatives, intermediates and preparing process thereof |
| 06/15/2004 | US6750238 Aralkyl ester soft drugs |
| 06/10/2004 | WO2004048380A1 Process for the synthesis of ganciclovir |
| 06/10/2004 | WO2004048379A1 Xanthine compound |
| 06/10/2004 | WO2004047769A2 Benzimidazoles and analogs thereof as antibacterials |
| 06/10/2004 | WO2004028445A3 Processes for preparing 1,3-dioxolane nucleosides |
| 06/10/2004 | WO2003102140A3 Cftr modifier genes and expressed polypeptides useful in treating cystic fibrosis |
| 06/10/2004 | WO2003033498A3 A process for the treatment of ganciclovir intermediate n2-acetyl-9-(1, 3-diacetoxy-2-propoxymethyl) guanine |
| 06/10/2004 | US20040110775 Cyclin dependent kinase inhibiting purine derivatives |
| 06/09/2004 | CN1503793A N-substituted nonabyl-heterocyclic nmda/nrzb antagonists |
| 06/08/2004 | US6747016 Substituted purine derivatives as inhibitors of cell adhesion |
| 06/03/2004 | WO2004046148A1 Novel xanthin derivatives, production and use thereof as medicaments |
| 06/03/2004 | WO2004046066A1 Method for deuteration or tritiation of heterocyclic ring |
| 06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
| 06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | WO2004009594A3 Xanthine derivatives having adenosine a1-receptor antagonist properties |
| 06/03/2004 | WO2003086371A3 Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 06/03/2004 | WO2003063800A8 8-heteroaryl xanthine adenosine a2b receptor antagonists |
| 06/03/2004 | US20040106797 8-ester function; metabolized by non-oxidative enzymes; primary metabolites are inactive; not subject to drug-drug interactions; water solubility and favorable metabolic profile |
| 06/03/2004 | US20040106635 Spiroisoquinoline compound, a method for preparing the same and an intermediate thereof |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | DE10254304A1 Neue Xanthinderivate, deren Herstellung und deren Verwendung als Arzneimittel New xanthine derivatives, their preparation and their use as medicaments |
| 06/03/2004 | CA2506720A1 New xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 06/03/2004 | CA2506010A1 A method for deuteration of a heterocyclic ring |
| 06/03/2004 | CA2503316A1 Method and compositions for temporarily incapacitating subjects |
| 06/03/2004 | CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/02/2004 | EP1424338A1 A process for preparing 2,6-dichloropurine |
| 06/02/2004 | EP1423391A1 Pyrrolo pyrimidines as agents for the inhibition of cystein proteases |
| 06/02/2004 | EP1423390A2 Purine inhibitors of phosphodiesterase (pde) 7 |
| 06/02/2004 | EP1423389A1 Pyrazolo-pyridines for the treatment of herpes infections |
| 06/02/2004 | EP1423107A2 Fatty alcohol drug conjugates |
| 06/02/2004 | EP1068210B1 Process for the production of purine derivatives |
| 06/02/2004 | CN1501941A Chemical compounds |
| 06/02/2004 | CN1501928A Small molecule compositions for binding to hsp90 |
| 06/02/2004 | CN1501927A Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
| 06/02/2004 | CN1500800A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV) |
| 06/02/2004 | CN1500782A Process for the diastereoselective synthesis of nucleoside analogues |
| 06/02/2004 | CN1152021C Intermediate for preparing corticotropin release factors antagonistic agent and preparing method thereof |
| 06/01/2004 | US6743919 2-aroylimidazole compounds for treating cancer |
| 06/01/2004 | US6743910 Stereoselective synthesis of nucleoside analogues |
| 06/01/2004 | US6743800 Vitronectin receptor antagonists and inhibitors of cell adhesion; osteoporosis, angiogenesis inhibitors |
| 06/01/2004 | US6743798 Cardiovascular disorders; vasorelaxation, inhibition of platelet aggregation, decrease in blood pressure; stimulation of soluble guanylate cyclase and an intracellular cgmp increase |
| 05/27/2004 | WO2004033455A3 Hemisuccinate salts of heterocyclic dpp-iv inhibitors |
| 05/27/2004 | US20040102628 Process for the synthesis of ganciclovir |
| 05/27/2004 | US20040102462 Viricides; bioavailability; 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy3-hydroxy-1-propanyl-L-valinate in diastereoisomer form |
| 05/27/2004 | US20040102461 Synergistic mixture with anticancer drugs |
| 05/27/2004 | US20040102460 Phosphodiesterase 4 inhibitors |
| 05/27/2004 | US20040102459 Central nervous system disorders; Parkinson's disease; antidepressants |
| 05/27/2004 | US20040102458 Antiproliferative agents; antitumor agents; binding to chaperone protein |
| 05/27/2004 | US20040102437 Prevention cytokine migration; hypotensive agents; asthma therapy |
| 05/27/2004 | US20040102432 Asthma, rhinitis therapy |
| 05/27/2004 | US20040101535 Administering nucleoside, or prodrug thereof; viricides |
| 05/26/2004 | EP1422553A1 Improved base precursors for use in a photothermographic element |
| 05/26/2004 | EP1421198A2 Cell-based high-throughput screening methods |
| 05/26/2004 | EP1420791A1 Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma |
| 05/26/2004 | EP1117642B1 Substituted 1,3-diaryl-2-pyridine-2-yl-3-(pyridine-2-ylamino)-propanol derivatives, methods for their production, pharmaceutical compositions containing the same and their use |
| 05/26/2004 | EP0740650B1 Codrugs as a method of controlled drug delivery |
| 05/26/2004 | CN1151167C Purine derivatives |
| 05/26/2004 | CN1151146C Process for diastereoselective synthesis of nucleoside analogues |
| 05/21/2004 | WO2004041820A1 Novel xanthine derivatives, the production and the use thereof in the form of drugs |
| 05/20/2004 | US20040097540 Adenosine a2a receptor antangonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 05/20/2004 | US20040097530 Novel heteroaryl derivatives and their use as medicaments |
| 05/20/2004 | US20040097528 For therapy |
| 05/20/2004 | US20040097510 For therapy of type I and type 11 diabetes mellitus, arthritis, obesity, or calcitonin-induced osteoporosis, allograft transplantation |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097461 Methods and compositions for treating hepatitis C Virus |
| 05/19/2004 | EP1420021A1 DNA Methyltransferase inhibitors |
| 05/19/2004 | EP1419157A2 HETEROCYCLIC COMPOUND BASED ON N sp 6 /sp −SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE |
| 05/19/2004 | EP0970078B1 Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides |
| 05/19/2004 | DE10251927A1 New 1,7,8-trisubstituted xanthine derivatives, are dipeptidylpeptidase-IV inhibitors useful e.g. for treating diabetes mellitus type I or II, arthritis or obesity |
| 05/19/2004 | CN1498221A Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
| 05/19/2004 | CN1150194C Carbocyclic nucleoside hemisufate and its use in treating viral infectiosn |